サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：コンピューター支援検出の世界市場 - 産業規模、シェア、動向、機会、予測：画像モダリティ別、用途別、企業別、地域別（2017年～2027年）
市場調査レポート
商品コード
1166580

コンピューター支援検出の世界市場 - 産業規模、シェア、動向、機会、予測：画像モダリティ別、用途別、企業別、地域別（2017年～2027年）

Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Imaging Modality, By Application, By Company and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 117 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

コンピューター支援検出の世界市場 - 産業規模、シェア、動向、機会、予測：画像モダリティ別、用途別、企業別、地域別（2017年～2027年）
出版日: 2022年12月01日
発行: TechSci Research
ページ情報: 英文 117 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のコンピューター支援検出市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されています。

主な要因としては、慢性疾患の発生率の上昇や技術の進歩などが挙げられ、これらは世界的に市場の成長を後押ししています。市場の成長を支えるその他の要因としては、認知度の向上、投資の拡大、人口の増加、ライフスタイルの変化、無機的な成長戦略の採用の増加、医療インフラに対する政府からの支援などが挙げられます。また、健康保険や医療ツーリズムの需要が徐々に高まっていることも、市場成長を後押しする重要な要因の一つと考えられています。

当レポートでは、世界のコンピューター支援検出市場について調査し、セグメント別の分析、市場力学、企業プロファイルなどの情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 世界のコンピューター支援検出市場に対するCOVID-19の影響

第4章 VOC (顧客の声)

第5章 エグゼクティブサマリー

第6章 世界のコンピューター支援検出市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 画像モダリティ別（マンモグラフィー、MRI、超音波、トモシンセシス、その他）
    • 用途別（腫瘍学、心血管疾患、神経疾患）
    • 企業別（2021年）
    • 地域別
  • 市場マップ

第7章 北米のコンピューター支援検出市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 画像モダリティ別（マンモグラフィー、MRI、超音波、トモシンセシス、その他）
    • 用途別（腫瘍学、心血管疾患、神経疾患）
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州のコンピューター支援検出市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 画像モダリティ別（マンモグラフィー、MRI、超音波、トモシンセシス、その他）
    • 用途別（腫瘍学、心血管疾患、神経疾患）
    • 国別
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋のコンピューター支援検出市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 画像モダリティ別（マンモグラフィー、MRI、超音波、トモシンセシス、その他）
    • 用途別（腫瘍学、心血管疾患、神経疾患）
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のコンピューター支援検出市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 画像モダリティ別（マンモグラフィー、MRI、超音波、トモシンセシス、その他）
    • 用途別（腫瘍学、心血管疾患、神経疾患）
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのコンピューター支援検出市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 画像モダリティ別（マンモグラフィー、MRI、超音波、トモシンセシス、その他）
    • 用途別（腫瘍学、心血管疾患、神経疾患）
    • 国別
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展

第14章 競合情勢

  • Hologic Inc.
  • GE Healthcare
  • Agfa-Gevaert N.V
  • iCAD, Inc.
  • Invivo Corporation
  • McKesson Corporation
  • Siemens Healthineers AG
  • EDDA technology, Inc.
  • FUJIFILM Medical Systems U.S.A., Inc.
  • Koninklijke Philips N.V.

第15章 戦略的提言

目次
Product Code: 12999

The global computer aided detection market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in incidences of chronic diseases and technological advancements, which are bolstering the growth of the market, globally. Computer aided detection (CAD) is a group of algorithms that use pattern identification to help physicians understand medical images. The computer aided detection software helps in the early diagnosis of various diseases such as cardiovascular diseases, cancer, chronic diseases, and neurological diseases through the imaging modalities, such as magnetic resonance imaging, x-rays imaging, ultrasound imaging, and computed tomography. The other factors supporting the market's growth are increasing awareness, growing investments, increase in population, changing lifestyle, increasing adoption of inorganic growth strategies and support from governments for healthcare infrastructure. Also, the gradual surge in demand for health insurance and medical tourism are some of the key factors that are projected to bolster the market growth.

Rising Prevalence of Chronic Diseases

Rising incidence of various chronic diseases such as stroke, various types of cancers, cardiovascular disorders, and neurological dysfunctions are increasing the demand of computer-aided detection, which propels the market growth, globally. Owing to the rapid change in lifestyles and environment, the number of cancer cases such as lung cancer, cervical cancer, breast cancer, prostate, and leukemia, are rising which enables the need for CAD. According to WHO, there is a probability of a 30% rise in the number of cancer cases by 2038. Computer-aided detection system assist doctors to detect cancer at early stages, reduce mortality rates for cancer and other diseases and also helps in decreasing the false negative rate, due to which people and multispecialty hospitals are opting for diagnostic imaging techniques. Thus, in turn, bolstering the growth of the market. According to the CDC, in the U.S., roughly 210,828 people were detected with lung cancer, including 99,433 women and 111,395 men. Also, in the U.S., 157,423 people died from lung cancer. Furthermore, due to the growing awareness among the patients about successful cancer treatment, is also a contributing factor for the growth of the market.

Technological Advancements and Increasing Investments

Over the past few years, rapid technological advancements are done in healthcare sector, which propels the market growth. Technological advancements like evolution of artificial intelligence (AI) and increase in sensitivity are projected to strengthen the continuous development of the global CAD market. For instance, in 2020, a study in work with data sets from the U.S. and the United Kingdom (U.K.) revealed that the AI model was able to successfully screen for breast cancer using only the pixel data given. Medical researchers and physicians are using medical imaging devices which are coupled with computer aided detection. Owing to the demand for error free detection, the demand for computational assistance is rising. Therefore, advanced digital imaging techniques are being improved for the better effectiveness and efficiencies of CAD solutions. In addition to these, major investments in R&D of computer aided detection with 3D imaging is augmenting the growth of the market.

Market Segmentation

The global computer aided detection market is segmented into imaging modality, application, and company. Based on imaging modality, the market is divided into mammography, MRI, ultrasound, tomosynthesis, and others. Based on application, the market is divided into oncology, cardiovascular diseases, and neurological disorders. Based on oncology, the market is further divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in incidence of various types of cancer in the country.

Market Players

Hologic Inc., GE Healthcare, Agfa-Gevaert N.V, iCAD, Inc., Invivo Corporation, McKesson Corporation, Siemens Healthineers AG, EDDA technology, Inc., FUJIFILM Medical Systems U.S.A., Inc., and Koninklijke Philips N.V. are some of the leading companies operating in the market.

Report Scope:

In this report, global computer aided detection market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Computer Aided Detection Market, By Imaging Modality:

Mammography

MRI

Ultrasound

Tomosynthesis

Others

  • Computer Aided Detection Market, By Application:

Oncology

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

Cardiovascular Diseases

Neurological Disorders

  • Computer Aided Detection Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

Europe & CIS

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in computer aided detection market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Computer Aided Detection Market

4. Voice of Customer

5. Executive Summary

6. Global Computer Aided Detection Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 6.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 6.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Market Map

7. North America Computer Aided Detection Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 7.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 7.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Computer Aided Detection Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Imaging Modality
        • 7.3.1.2.2. By Application
    • 7.3.2. Mexico Computer Aided Detection Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Imaging Modality
        • 7.3.2.2.2. By Application
    • 7.3.3. Canada Computer Aided Detection Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Imaging Modality
        • 7.3.3.2.2. By Application

8. Europe Computer Aided Detection Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 8.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 8.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Computer Aided Detection Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Imaging Modality
        • 8.3.1.2.2. By Application
    • 8.3.2. Germany Computer Aided Detection Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Imaging Modality
        • 8.3.2.2.2. By Application
    • 8.3.3. United Kingdom Computer Aided Detection Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Imaging Modality
        • 8.3.3.2.2. By Application
    • 8.3.4. Italy Computer Aided Detection Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Imaging Modality
        • 8.3.4.2.2. By Application
    • 8.3.5. Spain Computer Aided Detection Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Imaging Modality
        • 8.3.5.2.2. By Application

9. Asia-Pacific Computer Aided Detection Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 9.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 9.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Computer Aided Detection Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Imaging Modality
        • 9.3.1.2.2. By Application
    • 9.3.2. India Computer Aided Detection Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Imaging Modality
        • 9.3.2.2.2. By Application
    • 9.3.3. Japan Computer Aided Detection Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Imaging Modality
        • 9.3.3.2.2. By Application
    • 9.3.4. South Korea Computer Aided Detection Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Imaging Modality
        • 9.3.4.2.2. By Application
    • 9.3.5. Australia Computer Aided Detection Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Imaging Modality
        • 9.3.5.2.2. By Application

10. South America Computer Aided Detection Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 10.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 10.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Computer Aided Detection Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Imaging Modality
        • 10.3.1.2.2. By Application
    • 10.3.2. Argentina Computer Aided Detection Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Imaging Modality
        • 10.3.2.2.2. By Application
    • 10.3.3. Colombia Computer Aided Detection Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Imaging Modality
        • 10.3.3.2.2. By Application

11. Middle East and Africa Computer Aided Detection Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 11.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 11.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Computer Aided Detection Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Imaging Modality
        • 11.3.1.2.2. By Application
    • 11.3.2. Saudi Arabia Computer Aided Detection Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Imaging Modality
        • 11.3.2.2.2. By Application
    • 11.3.3. UAE Computer Aided Detection Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Imaging Modality
        • 11.3.3.2.2. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Hologic Inc.
  • 14.2. GE Healthcare
  • 14.3. Agfa-Gevaert N.V
  • 14.4. iCAD, Inc.
  • 14.5. Invivo Corporation
  • 14.6. McKesson Corporation
  • 14.7. Siemens Healthineers AG
  • 14.8. EDDA technology, Inc.
  • 14.9. FUJIFILM Medical Systems U.S.A., Inc.
  • 14.10. Koninklijke Philips N.V.

15. Strategic Recommendations